QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response. by Esmail, H, Thienemann, F, Oni, T, Goliath, R, Wilkinson, K, Wilkinson, R

Matrix Degradation in Human Immunodeficiency Virus Type 1-Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study. by Walker, N, Wilkinson, K, Meintjes, G, Tezera, L, Goliath, R, Peyper, J, Tadokera, R, Opondo, C, Coussens, A, Wilkinson, R, Friedland, J, Elkington, P

AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial by Zhao, Y, Keene, C, Griesel, R, Sayed, K, Gcwabe, Z, Jackson, A, Ngwenya, O, Schutz, C, Goliath, R, Cassidy, T, Goemaere, E, Hill, A, Maartens, G, Meintjes, G

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen by Keene, CM, Griesel, R, Zhao, Y, Gcwabe, Z, Sayed, K, Hill, A, Cassidy, T, Ngwenya, O, Jackson, A, van Zyl, G, Schutz, C, Goliath, R, Flowers, T, Goemaere, E, Wiesner, L, Simmons, B, Maartens, G, Meintjes, G

Coronary artery stenosis. by Weir, I

“…David Taggart has taken on the Goliath of interventional cardiology and its associated industry by persuasively marshalling the data from the evidence base which strongly favours surgery in triple vessel and left main coronary disease. …”

Tools for Test Case Generation. by Belinfante, A, Frantzen, L, Schallhart, C

“…In that sense testing is always a David vs. Goliath struggle, even when pragmatical approaches were chosen. …”